Atlas Trials

Open-Label Phase 3 Long-Term Safety Study of Migalastat

Clinical trial NCT01458119 · TERMINATED

Trial details

NCT number
NCT01458119
Sponsor
Amicus Therapeutics
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Fabry Disease
Start date
2011-10-14
Primary completion
2016-02-17
Enrollment
85

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.